Archives
-
TRPV1 and TRPA1 Drive TSLP in Nasal Epithelium
2026-09-11
The reference study shows that TRPV1 and TRPA1 are expressed in nasal epithelial cells and connect extracellular stimulation with TSLP production through calcium-dependent NFAT signaling. Its combined use of channel pharmacology, siRNA, calcium chelation, gene and protein measurements, and NFAT imaging provides a mechanistic framework for studying upper-airway inflammation and TRPA1 ion channel modulation.
-
ML365: TASK1 Workflows for Ion Channel Research
2026-09-10
ML365 combines nanomolar TASK1 inhibition with an orthogonal neuroinflammation use case, making it useful for both ion-current characterization and pathway-oriented target validation. This guide translates published aged-mouse findings into practical assay workflows while highlighting selectivity limits, assay-dependent potency, and troubleshooting checkpoints.
-
ML365: From TASK1 Mechanism to Translation
2026-09-10
ML365 connects selective TASK1 inhibition with membrane-potential biology, inflammasome signaling, and translational study design. This thought-leadership article examines evidence, assay causality, cross-domain relevance, and practical strategies for neurophysiology, cardiopulmonary, and potassium-channel research.
-
Cytochalasin D for Actin Uptake Assays
2026-09-09
Cytochalasin D provides a practical cytoskeletal perturbation for separating actin-dependent nanoparticle internalization from surface association. This guide adapts the approach to human corneal epithelial models while addressing dose selection, controls, viability, and interpretation across ocular, cancer, and antiviral workflows.
-
3-Deazaneplanocin (DZNep) Experimental Workflows
2026-09-09
Build reproducible DZNep experiments around dose-time matrices, epigenetic readouts, and phenotype-specific controls rather than relying on viability data alone. The workflow connects AML apoptosis studies, cancer stem cell targeting, hepatocellular carcinoma research, and metabolic disease models while highlighting where receptor-stratified assay design can improve interpretation.
-
(+)-Bicuculline: Practical GABAA Workflow
2026-09-08
(+)-Bicuculline (SKU N1592) is a water-insoluble, DMSO-soluble competitive GABAA receptor antagonist for controlled studies of inhibitory neurotransmission, synaptic NMDA receptor signaling modulation, and related neuronal assays. This guide focuses on stock preparation, storage, QC, and interpretation; it is a neuroscience research tool only and must not be used for diagnostic, therapeutic, or clinical purposes.
-
2,2,2-Trichloroethanol in Protein Analysis
2026-09-08
2,2,2-Trichloroethanol is a versatile small molecule biochemical for rapid in-gel protein visualization and orthogonal quality control in molecular biology research. This guide connects practical electrophoresis workflows with the dopamine transporter imaging strategy reported in a Parkinson’s disease cell-therapy model, while clearly separating established findings from assay-development recommendations.
-
Gemini Quaternary Ammonium Compounds: Study Insights
2026-09-07
Zivna and colleagues synthesized 16 novel gemini quaternary ammonium derivatives based on octenidine and evaluated their predicted membrane permeation, antibacterial, antibiofilm, antifungal, antiviral, and cytotoxic profiles. Compounds 6–8 and 12 were particularly notable, while compound 1 showed selective antifungal activity, illustrating how polarity and structural modification can reshape the balance between antimicrobial breadth, potency, solubility, and host-cell toxicity.
-
Dextromethorphan Hydrobromide: Research Workflow
2026-09-07
Build reproducible neuroprotection research workflows around Dextromethorphan hydrobromide, from NMDA-driven excitotoxicity assays to ion-channel validation. The guide combines practical dosing, formulation, controls, troubleshooting, and a clearly bounded comparison with PDK4 inhibitor discovery.
-
Dronedarone (Multaq) for AF Research Workflows
2026-09-05
Dronedarone (Multaq) is a useful exposure-aware probe for separating broad antiarrhythmic pharmacology from direct KCa2 channel modulation. This research-focused workflow covers solvent handling, automated patch clamp design, concentration selection, comparative controls, and troubleshooting for atrial fibrillation and atrial flutter studies.
-
Caspase-8 Fluorometric Assay Kit Workflow
2026-09-04
Turn IETD-dependent caspase activity into a quantitative fluorescence readout for apoptosis, drug-response, and cell-death mechanism studies. This workflow shows how to use the Caspase-8 Fluorometric Assay Kit alongside treatment controls and orthogonal validation, including hyperthermia–cisplatin experiments.
-
Cefotaxime in Antimicrobial Resistance Research
2026-09-04
Cefotaxime is a third-generation cephalosporin antibiotic used to investigate beta-lactam antibiotic mechanism, bacterial susceptibility, and resistance phenotypes. Its broad activity is experimentally useful, but beta-lactamase-mediated hydrolysis limits how resistance assays should be interpreted.
-
Cisapride (R 51619) in Cardiac Safety Screens
2026-09-03
Cisapride (R 51619) connects 5-HT4 receptor biology with hERG-mediated electrical risk, making it a useful challenge compound for integrated cardiotoxicity workflows. This guide shows how to combine controlled dosing, iPSC-derived cardiomyocyte imaging, and orthogonal electrophysiology to distinguish pathway activity from arrhythmogenic liability.
-
Cisapride B1198 for Reliable Cell Assays
2026-09-03
This scenario-driven guide explains how Cisapride (SKU B1198) can be incorporated into viability, cytotoxicity, and cardiac phenotypic workflows without confusing pharmacologic effects with nonspecific cell loss. It combines product-specific handling data with evidence from high-content iPSC-cardiomyocyte screening to improve assay interpretation and reproducibility.
-
YM 58483 (BTP2): A SOCE Assay Strategy
2026-09-02
YM 58483 (BTP2) is a powerful tool for resolving store-operated calcium entry in immune and fibrosis models. This guide focuses on assay design, causal interpretation, and the practical limits of pharmacologic SOCE blockade.